⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BCAX News
Bicara Therapeutics Inc. Common Stock
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BCAX
Form 8-K
sec.gov
BCAX
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BCAX
Form 8-K
sec.gov
BCAX
Bicara Therapeutics Reports Second Quarter 2026 Progress and Announces Strategic Leadership Transitions Marking Next Era of Execution and Growth
globenewswire.com
BCAX
Bicara Therapeutics to Report Second Quarter 2026 Financial Results and Business Updates on August 11, 2026, at 8:30 AM ET
globenewswire.com
BCAX
Form 8-K
sec.gov
BCAX
Bicara Therapeutics Announces Appointments of Jeremy Bender and Christy Oliger to Board of Directors
globenewswire.com
BCAX
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BCAX
Form 8-K
sec.gov
BCAX